7666 — Metis TechBio Balance Sheet
0.000.00%
- HK$13.74bn
- HK$13.89bn
- CNY105.00m
Annual balance sheet for Metis TechBio, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 1,013 | 788 | 1,126 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 5.71 | 11.3 | 12.5 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 1,026 | 819 | 1,149 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 106 | 73 | 96.1 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 1,313 | 1,049 | 1,290 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 98.2 | 109 | 172 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 2,291 | 2,431 | 249 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Treasury Stock | |||
| Other Equity | |||
| Total Equity | -978 | -1,382 | 1,041 |
| Total Liabilities & Shareholders' Equity | 1,313 | 1,049 | 1,290 |
| Total Common Shares Outstanding |